US Government Funding Opportunities for the Swiss Life Sciences Industry

Date

08.05.2019 17:30 - 20:00

Location

Biopôle, Bâtiment SC-C, Route de la Corniche 1, Epalinges

Register

Meet and learn more about the US Government contracting for Life Sciences companies.

The US Government awards $55B+ annually to Life Sciences organizations for R&D and procurement of drugs, biologicals, and medical devices. These awards provide an alternate source of non-dilutive financing for start-up biotech and life sciences organizations focused on R&D.

During the event, tow experts will share their insights. They include:

Stephen Morris, Ph.D., Managing Director, Industry Specialty Services- Biodefense and Government Contracting, BDO US
Theresia Yiallourou, Ph.D., Manager Consultant, Life Sciences

The presentations will provide an introduction to US Government contracting for Life Sciences companies. Attendees will leave with a basic understanding of what type of technology/innovations/R&D priorities are of interest to the US Government, how to identify opportunities and win awards, the associated risks and benefits of USG-funded programs, and the key attributes of a successful USG contractor.

The event is organised by BDO Switzerland.

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.